UGT1A7
Basic information
Region (hg38): 2:233681901-233773300
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (22 variants)
- Crigler-Najjar syndrome type 1 (6 variants)
- Crigler-Najjar syndrome (4 variants)
- UGT1A1-related disorder (4 variants)
- Hyperbilirubinemia (2 variants)
- Gilbert syndrome (2 variants)
- Crigler-Najjar syndrome, type II (2 variants)
- Crigler-Najjar syndrome type 1;Gilbert syndrome;Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT1A7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 28 | ||||
missense | 85 | 107 | ||||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 15 | 11 | 157 | 41 | 23 | 247 |
Total | 26 | 23 | 256 | 68 | 30 |
Highest pathogenic variant AF is 0.0000919
Variants in UGT1A7
This is a list of pathogenic ClinVar variants found in the UGT1A7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-233681970-C-A | Benign (Nov 30, 2023) | |||
2-233682005-C-A | not specified | Uncertain significance (May 09, 2022) | ||
2-233682041-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
2-233682060-G-A | not specified | Uncertain significance (Nov 30, 2018) | ||
2-233682109-G-T | not specified | Uncertain significance (Jun 22, 2021) | ||
2-233682129-G-A | Uncertain significance (Mar 27, 2023) | |||
2-233682180-C-A | Uncertain significance (Dec 20, 2023) | |||
2-233682199-C-T | Uncertain significance (Feb 22, 2020) | |||
2-233682205-T-C | not specified | Uncertain significance (May 01, 2019) | ||
2-233682211-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
2-233682220-G-A | not specified | Likely benign (Sep 17, 2021) | ||
2-233682278-A-G | Uncertain significance (Dec 23, 2022) | |||
2-233682280-G-A | Likely benign (Jul 26, 2023) | |||
2-233682289-G-T | Uncertain significance (Jun 27, 2018) | |||
2-233682301-T-C | not specified | Uncertain significance (Aug 09, 2021) | ||
2-233682323-A-G | Likely benign (Nov 30, 2023) | |||
2-233682323-AT-GG | Likely benign (Nov 30, 2023) | |||
2-233682324-T-G | Benign (Nov 30, 2023) | |||
2-233682328-C-A | Benign (Nov 30, 2023) | |||
2-233682328-CG-AA | Benign (Nov 30, 2023) | |||
2-233682329-G-A | Benign (Nov 30, 2023) | |||
2-233682354-G-C | Likely benign (Sep 14, 2023) | |||
2-233682359-G-C | Uncertain significance (Jul 02, 2021) | |||
2-233682404-T-C | not specified | Uncertain significance (Feb 28, 2023) | ||
2-233682412-A-G | not specified | Uncertain significance (Mar 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UGT1A7 | protein_coding | protein_coding | ENST00000373426 | 5 | 91362 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.66e-14 | 0.0195 | 125537 | 0 | 211 | 125748 | 0.000839 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.411 | 314 | 294 | 1.07 | 0.0000173 | 3463 |
Missense in Polyphen | 142 | 135.35 | 1.0492 | 1605 | ||
Synonymous | -2.56 | 150 | 115 | 1.30 | 0.00000726 | 1049 |
Loss of Function | -0.0316 | 20 | 19.8 | 1.01 | 0.00000118 | 237 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00585 | 0.00586 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000544 | 0.000544 |
Finnish | 0.000647 | 0.000647 |
European (Non-Finnish) | 0.000550 | 0.000545 |
Middle Eastern | 0.000544 | 0.000544 |
South Asian | 0.000621 | 0.000621 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1. {ECO:0000269|PubMed:23360619}.;
- Pathway
- Retinol metabolism - Homo sapiens (human);Steroid hormone biosynthesis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Mycophenolic acid Pathway, Pharmacokinetics;Mycophenolic acid Pathway, Pharmacokinetics/Pharmacodynamics;Mycophenolic Acid Metabolism Pathway;Aryl Hydrocarbon Receptor Pathway;Nuclear Receptors Meta-Pathway;NRF2 pathway;Glucuronidation;Metapathway biotransformation Phase I and II;Glucuronidation;Phase II - Conjugation of compounds;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Biological oxidations;Metabolism;Linoleate metabolism;Vitamin A (retinol) metabolism;Xenobiotics metabolism;Porphyrin metabolism
(Consensus)
Recessive Scores
- pRec
- 0.581
Intolerance Scores
- loftool
- 0.989
- rvis_EVS
- -0.15
- rvis_percentile_EVS
- 42.23
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0472
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ugt1a9
- Phenotype
Gene ontology
- Biological process
- excretion;coumarin metabolic process;drug metabolic process;retinoic acid metabolic process;negative regulation of catalytic activity;flavone metabolic process;cellular glucuronidation;flavonoid glucuronidation;xenobiotic glucuronidation
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;intracellular membrane-bounded organelle
- Molecular function
- retinoic acid binding;enzyme inhibitor activity;protein kinase C binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity;protein homodimerization activity;protein heterodimerization activity